tirzepatide deadline nears for discounted weight loss drugs: What to know The Tirzepatide Shortage Is Over:

Tirzepatide is a once-weekly injection you administer at home

Studies show weight reduction of up to It can be tempting to discuss an earlier increase in your semaglutide dose for faster weight loss results, but that can lead to negative consequences, such as side effects (nausea, vomiting, other undesirable gastrointestinal symptoms, etc.)

FDA-approved pharmacotherapy alternatives include several options with established safety profiles: Semaglutide (Wegovy): A GLP-1 receptor agonist producing 12-15% weight loss, with cardiovascular benefits demonstrated in the SELECT trial and FDA-approved indication for reducing cardiovascular risk Liraglutide (Saxenda): A GLP-1 receptor agonist producing 5-8% weight loss [4] Phentermine-topiramate (Qsymia): FDA-approved combination producing 7-10% weight loss with established safety data Naltrexone-bupropion (Contrave): Combination targeting reward pathways and appetite, producing 5-9% weight loss [4] Orlistat (Xenical, Alli): Lipase inhibitor producing 3-5% weight loss with gastrointestinal side effects [4] Setmelanotide (Imcivree): For rare genetic obesity disorders (POMC, PCSK1, LEPR deficiency) [4] Metabolic and bariatric surgery should be considered for patients with BMI 40 kg/m or 35 kg/m with obesity-related comorbidities who have not achieved adequate weight loss with nonsurgical interventions

Ozempic is used to improve glycemic control in people with type 2 diabetes

Among the 4 GLP-1RAs, Semaglutide was the most cost-effective obesity medication [38] [39]

There are many different types, each with their own advantages and drawbacks